These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7942619)

  • 41. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
    Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
    Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blinded review of archival radical prostatectomy specimens supports that contemporary Gleason score 6 prostate cancer lacks metastatic potential.
    Nunez Bragayrac LA; Murekeyisoni C; Vacchio MJ; Attwood K; Mehedint DC; Mohler JL; Azabdaftari G; Xu B; Kauffman EC
    Prostate; 2017 Jul; 77(10):1076-1081. PubMed ID: 28547760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Bill-Axelson A; Holmberg L; Ruutu M; Garmo H; Stark JR; Busch C; Nordling S; Häggman M; Andersson SO; Bratell S; Spångberg A; Palmgren J; Steineck G; Adami HO; Johansson JE;
    N Engl J Med; 2011 May; 364(18):1708-17. PubMed ID: 21542742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911).
    van der Kwast TH; Collette L; Van Poppel H; Van Cangh P; Vekemans K; DaPozzo L; Bosset JF; Kurth KH; Schröder FH; Bolla M;
    Virchows Arch; 2006 Oct; 449(4):428-34. PubMed ID: 16941153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy-associated effects in the prostate gland.
    Srigley JR; Delahunt B; Evans AJ
    Histopathology; 2012 Jan; 60(1):153-65. PubMed ID: 22212084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small core needle biopsies in cytology practice: a survey of members of the American Society of Cytopathology.
    Thrall MJ; Vrbin C; Barkan GA; Monaco SE; Pambuccian SE; Pantanowitz L; Pitman MB; Kurtycz DFI
    J Am Soc Cytopathol; 2020; 9(5):310-321. PubMed ID: 32653451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing prostate specimen handling for diagnosis and prognosis.
    Bostwick DG; Day CE; Meiers I
    Methods Mol Biol; 2014; 1180():337-52. PubMed ID: 25015158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
    Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
    BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
    Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
    Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
    J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is a single focus of low-grade prostate cancer diagnosed on saturation biopsy predictive of clinically insignificant cancer?
    Pepe P; Fraggetta F; Galia A; Candiano G; Grasso G; Aragona F
    Urol Int; 2010; 84(4):440-4. PubMed ID: 20234121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The correlation among the percentage of positive biopsy cores from the dominant side of prostate, adverse pathology, and biochemical failure after radical prostatectomy.
    Memis A; Ugurlu O; Ozden C; Oztekin CV; Aktas BK; Akdemir AO
    Kaohsiung J Med Sci; 2011 Aug; 27(8):307-13. PubMed ID: 21802641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive factors in prostate needle biopsy.
    Mazzucchelli R; Lopéz-Beltran A; Scarpelli M; Montironi R
    Pathologica; 2002 Dec; 94(6):331-7. PubMed ID: 12541000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffuse adenosis of the peripheral zone in prostate needle biopsy and prostatectomy specimens.
    Lotan TL; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1360-6. PubMed ID: 18670353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fraction of positive cores in prostate needle biopsy is significantly predictive of pathological stage in radical prostatectomy.
    Brimo F; Vollmer RT; Bismar TA
    Histopathology; 2009 Feb; 54(3):374-5. PubMed ID: 19236514
    [No Abstract]   [Full Text] [Related]  

  • 59. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
    Smith EB; Frierson HF; Mills SE; Boyd JC; Theodorescu D
    Cancer; 2002 Apr; 94(8):2282-7. PubMed ID: 12001128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.